Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina



New biotechnology joint venture set up in Cuba

New biotechnology joint venture set up in Cuba

Havana, Sep 1 (Prensa Latina) A new joint venture for the development and marketing of innovative biotechnology products named IncuBIO Co. was created in Cuba, an official report revealed today.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

Quoted by Granma newspaper the report added that this company is located in Mariel Special Development Zone (ZEDM). It is a partnership between local company Cimab Co. and Neuronic Mexicana Co.

According to additional information on the website of the Ministry of Foreign Trade and Investment (Mincex), IncuBIO is designed to attract venture capital, and its shares may be acquired by future investors.

It seeks to increase the value of these products by financing clinical trials in underdeveloped country.

Among the innovative products it will market is NeuroEPO, one of the most promising assets in the portfolio of Cuba’s Molecular Immunology Center.

Such drug is being tested as a treatment for various neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and ataxia.

With IncuBIO, Cimab becomes a shareholder of five joint ventures located in China, Thailand, Singapore and Cuba.


name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.